IL233075A0 - Transmucosal drug release devices for use in chronic pain relief - Google Patents

Transmucosal drug release devices for use in chronic pain relief

Info

Publication number
IL233075A0
IL233075A0 IL233075A IL23307514A IL233075A0 IL 233075 A0 IL233075 A0 IL 233075A0 IL 233075 A IL233075 A IL 233075A IL 23307514 A IL23307514 A IL 23307514A IL 233075 A0 IL233075 A0 IL 233075A0
Authority
IL
Israel
Prior art keywords
drug delivery
delivery devices
chronic pain
pain relief
transmucosal drug
Prior art date
Application number
IL233075A
Other languages
English (en)
Hebrew (he)
Original Assignee
Biodelivery Sciences Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodelivery Sciences Int Inc filed Critical Biodelivery Sciences Int Inc
Publication of IL233075A0 publication Critical patent/IL233075A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL233075A 2011-12-21 2014-06-11 Transmucosal drug release devices for use in chronic pain relief IL233075A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161578755P 2011-12-21 2011-12-21
PCT/US2012/071330 WO2013096811A2 (en) 2011-12-21 2012-12-21 Transmucosal drug delivery devices for use in chronic pain relief

Publications (1)

Publication Number Publication Date
IL233075A0 true IL233075A0 (en) 2014-07-31

Family

ID=48669710

Family Applications (2)

Application Number Title Priority Date Filing Date
IL233075A IL233075A0 (en) 2011-12-21 2014-06-11 Transmucosal drug release devices for use in chronic pain relief
IL285091A IL285091A (en) 2011-12-21 2021-07-23 Transmucosal drug release devices for use in chronic pain relief

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL285091A IL285091A (en) 2011-12-21 2021-07-23 Transmucosal drug release devices for use in chronic pain relief

Country Status (16)

Country Link
EP (1) EP2793870A4 (es)
JP (1) JP6255349B2 (es)
KR (4) KR20210003313A (es)
CN (2) CN104125828A (es)
AU (4) AU2012358308A1 (es)
BR (1) BR112014015329A2 (es)
CA (1) CA2859859A1 (es)
EA (2) EA201992762A1 (es)
HK (1) HK1203365A1 (es)
IL (2) IL233075A0 (es)
IN (1) IN2014DN06117A (es)
MX (2) MX362217B (es)
SG (3) SG11201403075XA (es)
UA (1) UA118540C2 (es)
WO (1) WO2013096811A2 (es)
ZA (1) ZA201804381B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021163529A2 (en) * 2020-02-13 2021-08-19 Biodelivery Sciences International, Inc. Methods of treatment with buprenorphine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
DE19652188C2 (de) * 1996-12-16 2002-02-14 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
AU776904B2 (en) 2000-02-08 2004-09-23 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
WO2002088157A1 (fr) 2001-04-27 2002-11-07 Ajinomoto Co., Inc. Derives pyrazolyl-o-glycoside n-substitues et medicament contre le diabete en contenant
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
DE102005007859A1 (de) * 2005-02-21 2006-08-24 Lts Lohmann Therapie-Systeme Ag Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen
US20060281775A1 (en) * 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
WO2007070632A2 (en) * 2005-12-13 2007-06-21 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
AU2007238092A1 (en) 2006-04-12 2007-10-25 Spinalmotion, Inc. Posterior spinal device and method
AU2007275581B2 (en) * 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
EP1897543A1 (en) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
GB0620661D0 (en) * 2006-10-18 2006-11-29 Pharmasol Ltd Novel compounds
GB2447016A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Buprenorphine/naloxone compositions
CN102056578A (zh) * 2008-06-23 2011-05-11 生物递送科学国际公司 多向粘膜给药装置及使用方法
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions

Also Published As

Publication number Publication date
MX2014007350A (es) 2014-09-15
UA118540C2 (uk) 2019-02-11
SG11201403075XA (en) 2014-07-30
AU2021202042A1 (en) 2021-04-29
EP2793870A4 (en) 2016-02-17
SG10202012743WA (en) 2021-01-28
CA2859859A1 (en) 2013-06-27
EA201491046A1 (ru) 2014-11-28
IN2014DN06117A (es) 2015-08-14
WO2013096811A3 (en) 2014-07-24
KR20140106720A (ko) 2014-09-03
SG10201710667YA (en) 2018-02-27
BR112014015329A8 (pt) 2017-06-13
KR20210003313A (ko) 2021-01-11
AU2019202602A1 (en) 2019-05-02
CN104125828A (zh) 2014-10-29
HK1203365A1 (en) 2015-10-30
IL285091A (en) 2021-08-31
MX2021012154A (es) 2021-11-03
ZA201804381B (en) 2022-12-21
KR20190110628A (ko) 2019-09-30
AU2017258916A1 (en) 2017-11-30
AU2017258916B2 (en) 2019-01-17
KR102026321B1 (ko) 2019-09-27
BR112014015329A2 (pt) 2017-06-13
MX362217B (es) 2019-01-09
WO2013096811A2 (en) 2013-06-27
EP2793870A2 (en) 2014-10-29
JP2015500886A (ja) 2015-01-08
EA201992762A1 (ru) 2020-07-31
JP6255349B2 (ja) 2017-12-27
CN110123792A (zh) 2019-08-16
KR20220047889A (ko) 2022-04-19
AU2012358308A1 (en) 2014-07-24
EA034529B1 (ru) 2020-02-18

Similar Documents

Publication Publication Date Title
HK1200388A1 (en) Fixed-dose medicament delivery device
HK1198139A1 (en) Drug delivery medical device
IL232768A0 (en) A drug delivery device
ZA201307378B (en) Medicament delivery device
GB2479953B (en) Drug delivery device
IL227712A0 (en) Device for sending medicine
HK1179542A1 (zh) 藥物遞送裝置
SG10201503939SA (en) Drug delivery device
EP2544741A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
EP2533834A4 (en) APPARATUS FOR MEDICAMENT ADMINISTRATION
EP2897598A4 (en) TRANSDERMIC DRUG DELIVERY DEVICE
ZA201302588B (en) Medicament delivery device
EP2640448A4 (en) DEVICE FOR DISTRIBUTING MEDICINE
PL2616133T3 (pl) Aparaty do podawania leków przez skórę
EP2788053A4 (en) DEVICE FOR DELIVERING MEDICAMENTS
ZA201306604B (en) Drug delivery device
EP2640449A4 (en) DEVICE FOR DISTRIBUTING MEDICINE
ZA201208185B (en) Intravaginall drug delivery device
EP2560711A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
IL285091A (en) Transmucosal drug release devices for use in chronic pain relief
IL232390A0 (en) Device for upgraded pressure treatment in small doses and drug injection
EP2706962A4 (en) SURFACE CHARACTERISTICS OF DRUG RETENTION IN AN IMPLANTABLE MEDICAL DEVICE
EP2626055A4 (en) ACTIVE RELEASE DEVICE